skip to main content
Results 1 2 3 4 5 next page
Show only
Refined by: collection: Journals@Ovid Full Text remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
Material Type:
Article
Add to e-Shelf

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

Cortot, Alexis B ; Kherrouche, Zoulika ; Descarpentries, Clotilde ; Wislez, Marie ; Baldacci, Simon ; Furlan, Alessandro ; Tulasne, David

JNCI : Journal of the National Cancer Institute, 2017-05, Vol.109 (5) [Peer Reviewed Journal]

United States: Oxford University Press (OUP)

Full text available

2
Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma
Material Type:
Article
Add to e-Shelf

Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma

Puls, Florian ; Agaimy, Abbas ; Flucke, Uta ; Mentzel, Thomas ; Sumathi, Vaiyapuri P ; Ploegmakers, Marieke ; Stoehr, Robert ; Kindblom, Lars-Gunnar ; Hansson, Magnus ; Sydow, Saskia ; Arbajian, Elsa ; Mertens, Fredrik

The American journal of surgical pathology, 2020-05, Vol.44 (5), p.594-606 [Peer Reviewed Journal]

United States: Copyright Wolters Kluwer Health, Inc. All rights reserved

Full text available

3
Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita
Material Type:
Article
Add to e-Shelf

Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita

Kirschner, Martin ; Maurer, Angela ; Wlodarski, Marcin W ; Ventura Ferreira, Monica S ; Bouillon, Anne-Sophie ; Halfmeyer, Insa ; Blau, Wolfgang ; Kreuter, Michael ; Rosewich, Martin ; Corbacioglu, Selim ; Beck, Joachim ; Schwarz, Michaela ; Bittenbring, Jörg ; Radsak, Markus P ; Wilk, Christian Matthias ; Koschmieder, Steffen ; Begemann, Matthias ; Kurth, Ingo ; Schemionek, Mirle ; Brümmendorf, Tim H ; Beier, Fabian

Leukemia, 2018-08, Vol.32 (8), p.1762-1767 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

4
Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia
Material Type:
Article
Add to e-Shelf

Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia

Bagacean, Cristina ; Iuga, Cristina Adela ; Bordron, Anne ; Tempescul, Adrian ; Pralea, Ioana‐Ecaterina ; Bernard, Delphine ; Cornen, Melanie ; Bergot, Tiffany ; Le Dantec, Christelle ; Brooks, Wesley ; Saad, Hussam ; Ianotto, Jean‐Christophe ; Pers, Jacques‐Olivier ; Zdrenghea, Mihnea ; Berthou, Christian ; Renaudineau, Yves

Journal of leukocyte biology, 2022-02, Vol.111 (2), p.313-325 [Peer Reviewed Journal]

United States: Society for Leukocyte Biology

Full text available

5
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Material Type:
Article
Add to e-Shelf

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

Behan, Fiona M ; Iorio, Francesco ; Picco, Gabriele ; Gonçalves, Emanuel ; Beaver, Charlotte M ; Migliardi, Giorgia ; Santos, Rita ; Rao, Yanhua ; Sassi, Francesco ; Pinnelli, Marika ; Ansari, Rizwan ; Harper, Sarah ; Jackson, David Adam ; McRae, Rebecca ; Pooley, Rachel ; Wilkinson, Piers ; van der Meer, Dieudonne ; Dow, David ; Buser-Doepner, Carolyn ; Bertotti, Andrea ; Trusolino, Livio ; Stronach, Euan A ; Saez-Rodriguez, Julio ; Yusa, Kosuke ; Garnett, Mathew J

Nature (London), 2019-04, Vol.568 (7753), p.511-516 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

6
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Material Type:
Article
Add to e-Shelf

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Mateo, J. ; Chakravarty, D. ; Dienstmann, R. ; Jezdic, S. ; Gonzalez-Perez, A. ; Lopez-Bigas, N. ; Ng, C.K.Y. ; Bedard, P.L. ; Tortora, G. ; Douillard, J.-Y. ; Van Allen, E.M. ; Schultz, N. ; Swanton, C. ; André, F. ; Pusztai, L.

Annals of oncology, 2018-09, Vol.29 (9), p.1895-1902 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

7
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
Material Type:
Article
Add to e-Shelf

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology

Sepulveda, Antonia R ; Hamilton, Stanley R ; Allegra, Carmen J ; Grody, Wayne ; Cushman-Vokoun, Allison M ; Funkhouser, William K ; Kopetz, Scott E ; Lieu, Christopher ; Lindor, Noralane M ; Minsky, Bruce D ; Monzon, Federico A ; Sargent, Daniel J ; Singh, Veena M ; Willis, Joseph ; Clark, Jennifer ; Colasacco, Carol ; Rumble, R Bryan ; Temple-Smolkin, Robyn ; Ventura, Christina B ; Nowak, Jan A

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1453-1486 [Peer Reviewed Journal]

United States

Full text available

8
Immunological differences between primary and metastatic breast cancer
Material Type:
Article
Add to e-Shelf

Immunological differences between primary and metastatic breast cancer

Szekely, B. ; Bossuyt, V. ; Li, X. ; Wali, V.B. ; Patwardhan, G.A. ; Frederick, C. ; Silber, A. ; Park, T. ; Harigopal, M. ; Pelekanou, V. ; Zhang, M. ; Yan, Q. ; Rimm, D.L. ; Bianchini, G. ; Hatzis, C. ; Pusztai, L.

Annals of oncology, 2018-11, Vol.29 (11), p.2232-2239 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

9
Neoantigens in cancer immunotherapy
Material Type:
Article
Add to e-Shelf

Neoantigens in cancer immunotherapy

Schumacher, Ton N. ; Schreiber, Robert D.

Science (American Association for the Advancement of Science), 2015-04, Vol.348 (6230), p.69-74 [Peer Reviewed Journal]

United States: American Association for the Advancement of Science

Full text available

10
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Material Type:
Article
Add to e-Shelf

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Powles, Thomas ; Assaf, Zoe June ; Davarpanah, Nicole ; Banchereau, Romain ; Szabados, Bernadett E ; Yuen, Kobe C ; Grivas, Petros ; Hussain, Maha ; Oudard, Stephane ; Gschwend, Jürgen E ; Albers, Peter ; Castellano, Daniel ; Nishiyama, Hiroyuki ; Daneshmand, Siamak ; Sharma, Shruti ; Zimmermann, Bernhard G ; Sethi, Himanshu ; Aleshin, Alexey ; Perdicchio, Maurizio ; Zhang, Jingbin ; Shames, David S ; Degaonkar, Viraj ; Shen, Xiaodong ; Carter, Corey ; Bais, Carlos ; Bellmunt, Joaquim ; Mariathasan, Sanjeev

Nature (London), 2021-07, Vol.595 (7867), p.432-437 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Full Text Online (30,211)
  2. Peer-reviewed Journals (29,377)

Refine My Results

Resource Type 

  1. Articles  (31,830)
  2. Book Chapters  (1)
  3. More options open sub menu

Creation Date 

From To
  1. Before1990  (60)
  2. 1990To1998  (1,044)
  3. 1999To2007  (4,418)
  4. 2008To2017  (14,975)
  5. After 2017  (11,335)
  6. More options open sub menu

Language 

  1. English  (31,813)
  2. Japanese  (6,009)
  3. Norwegian  (17)
  4. Russian  (14)
  5. German  (14)
  6. Chinese  (7)
  7. Italian  (4)
  8. French  (3)
  9. Dutch  (1)
  10. More options open sub menu

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far